Canagliflozin as an Initial Therapy in Drug-Naïve Subjects with Type 2 Diabetes Mellitus: A Potential Involvement of Atherogenic Lipids in its Glycemic Efficacy

BACKGROUND AND OBJECTIVES: The aim of this study is to investigate canagliflozin as an initial therapy in type 2 diabetes mellitus and to explore the effects on metabolic parameters in relation to effects on glycemic control. SUBJECTS AND METHODS: Treatment-naïve subjects with type 2 diabetes mellit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutoh, Eiji, Wada, Asuka, Murayama, Teruma, Takizawa, Yui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427050/
https://www.ncbi.nlm.nih.gov/pubmed/28285448
http://dx.doi.org/10.1007/s40268-017-0179-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427050/
https://www.ncbi.nlm.nih.gov/pubmed/28285448
http://dx.doi.org/10.1007/s40268-017-0179-7

Ejemplares similares